April 25th-27th, 2018 (Oxon Hill, MD): World Orphan Drug Congress

Executive Director, Vanessa Vogel-Falrley, attened the World Orphan Drug Congress meeting April 25th-27th, 2018 (Oxon Hill, MD): 

USA focuses on the most pressing challenges and opportunities to bring rare disease therapies to patients faster. Bringing together a global gathering of 1,200 leaders in orphan drugs from 50 countries, World Orphan Drug Congress USA will feature over 135 presentations covering all aspects of orphan drug development and rare disease research.